SUSI ROGER E. (CEO, PRESIDENT, CHAIRMAN) sold 0.2% of their position (5K shares) of IRADIMED CORP on the open market
Open‑market sale worth $483.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/17/2025ACC: 0001613801-25-000038
DirectorOfficer10% Owner· CEO, PRESIDENT, CHAIRMAN
Since Mar 2026
-5K
Net shares
Net seller
$483.7K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
5K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−4.27K
Price / share
$96.68
Trade value
$412.73K
% of position
0.2%
12/15/2025
2.30M→2.29M
Common Stock
Indirect
Shares
−731.00
Price / share
$97.13
Trade value
$71K
% of position
0.0%
12/15/2025
2.29M→2.29M
Total
Net shares
−5K
Net value
-$483.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/15/2025 | S · Sale | −4.27K | $96.68 | $412.73K | 0.2% | 2.30M | 2.29M |
| Common Stock Indirect | 12/15/2025 | S · Sale | −731.00 | $97.13 | $71K | 0.0% | 2.29M | 2.29M |
| Total | −5K | -$483.73K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned2.06M
Common Stock
IndirectShares owned162.95K
Total
2.23M indirect2.23M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.06M | Indirect |
| Common Stock | 162.95K | Indirect |
| Total | 2.23M | 2.23M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported